azathioprine has been researched along with Primary Immunodeficiency Diseases in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Primary Immunodeficiency Diseases: Genetic immunologic deficiency diseases and syndromes due to mutations in genes involved in IMMUNITY generally characterized by an increased susceptibility to infectious diseases. They are often associated with AUTOIMMUNE DISEASE manifestations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Both, T | 1 |
| Dalm, VASH | 1 |
| Richardson, SA | 1 |
| van Schie, N | 1 |
| van den Broek, LM | 1 |
| de Vries, AC | 1 |
| van Hagen, PM | 1 |
| Rombach, SM | 1 |
1 review available for azathioprine and Primary Immunodeficiency Diseases
| Article | Year |
|---|---|
Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review.
Topics: Azathioprine; Delayed Diagnosis; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Prim | 2021 |